Patents by Inventor Jimin JEON

Jimin JEON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250040189
    Abstract: A display device according to an embodiment includes a substrate and a transistor including an oxide semiconductor layer and a gate electrode disposed on the oxide semiconductor layer. The oxide semiconductor layer includes a channel region and a first source region disposed adjacent to the channel region and a second source region disposed adjacent to the first source region, and the drain region include a first drain region disposed adjacent to the channel region and a second drain region disposed adjacent to the first drain region. Each of the first source region and the first drain region includes a first impurity ion, and each of the second source region and the second drain region includes a second impurity ion which are different from the first impurity.
    Type: Application
    Filed: January 12, 2024
    Publication date: January 30, 2025
    Inventors: Sang Jin PARK, DAEGEON KIM, JIMIN PARK, JINSEOK SEO, YONGHAN LEE, YOOGANG JEON
  • Patent number: 11672815
    Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: June 13, 2023
    Assignee: CUPIONE CO., LTD.
    Inventors: Siyoung Yang, Jimin Jeon, Li-Jung Kang, Chanmi Cho
  • Publication number: 20220362270
    Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.
    Type: Application
    Filed: December 29, 2021
    Publication date: November 17, 2022
    Applicant: CUPIONE CO., LTD.
    Inventors: Siyoung YANG, Jimin JEON, Li-Jung KANG, Chanmi CHO
  • Patent number: 11372404
    Abstract: A method performed by an apparatus is described. The method includes receiving remote data. The method also includes adapting model processing based on the remote data. The method further includes determining a driving decision based on the adapted model processing. In some examples, adapting model processing may include selecting a model, adjusting model scheduling, and/or adjusting a frame computation frequency.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: June 28, 2022
    Assignee: QUALCOMM Incorporated
    Inventors: Seungwoo Yoo, Jimin Jeon, Hyun-Mook Cho
  • Patent number: 11291676
    Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: April 5, 2022
    Assignee: CUPIONE CO., LTD.
    Inventors: Siyoung Yang, Jimin Jeon, Li-Jung Kang, Chanmi Cho
  • Publication number: 20210236525
    Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.
    Type: Application
    Filed: February 2, 2021
    Publication date: August 5, 2021
    Applicant: CUPIONE CO., LTD.
    Inventors: Siyoung YANG, Jimin JEON, Li-Jung KANG, Chanmi CHO
  • Publication number: 20200272149
    Abstract: A method performed by an apparatus is described. The method includes receiving remote data. The method also includes adapting model processing based on the remote data. The method further includes determining a driving decision based on the adapted model processing. In some examples, adapting model processing may include selecting a model, adjusting model scheduling, and/or adjusting a frame computation frequency.
    Type: Application
    Filed: February 22, 2019
    Publication date: August 27, 2020
    Inventors: Seungwoo Yoo, Jimin Jeon, Hyun-Mook Cho
  • Publication number: 20200138837
    Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.
    Type: Application
    Filed: November 18, 2019
    Publication date: May 7, 2020
    Applicant: SYNOVIZEN CO., LTD.
    Inventors: Siyoung YANG, Jimin JEON, Li-Jung KANG, Chanmi CHO
  • Publication number: 20190030054
    Abstract: Provided are a composition for inhibiting immune cell proliferation, including sialyllactose or a derivative thereof as an active ingredient, and a method of inhibiting immune cell proliferation, wherein the composition and the method may decrease expression of chemokines, decrease expression of pro-inflammatory cytokines, decrease production of inflammatory mediators, decrease expression of COX2, and decrease production of PEG2, and therefore, may be useful for the prevention or treatment of atopic dermatitis or arthritis.
    Type: Application
    Filed: September 13, 2018
    Publication date: January 31, 2019
    Applicant: AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Siyoung YANG, Jimin JEON, Li-Jung KANG, Chanmi CHO